Abstract: The present application relates to a battery cell and a manufacturing method and device thereof, a battery, and a power consumption apparatus, belonging to the field of battery manufacturing technologies. The battery cell includes: a shell with a first wall; an electrode assembly; and a first current collecting member, where the first wall has a first surface facing the first current collecting member, the first current collecting member has a second surface facing the first wall, one of the first surface and the second surface is provided with a protrusion and the other abuts against the protrusion to form a gap between the first wall and the first current collecting member; and the first current collecting member is provided with a first hole and a second hole, and the first hole is configured to be in communication with the second hole through the gap.

Abstract: The present disclosure features citrate salts and pharmaceutical compositions useful for the treatment of BAF complex-related disorders. Also disclosed are methods for preparing compounds.

Abstract: Disclosed are crystalline forms of the compound of formula (I): (I) Also disclosed are compositions containing the crystalline forms of the compound of formula (I) and methods of their use. The methods may be for treating cancer in a subject in need thereof, e.g., by administering to the subject an effective amount of the crystalline form disclosed herein or its composition.

Abstract: The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Abstract: Provided are compounds useful for treating of cancer and methods for treating of cancer, comprising administering to a subject in need thereof a compound described therein.

Abstract: This application provides a battery cell, a battery, and an electrical device, and relates to the technical field of batteries. The battery cell includes an electrode assembly. A plurality of weld portions are disposed on one side of a first electrode plate of the electrode assembly along a width direction. The plurality of weld portions are spaced apart along a length direction of the first electrode plate. The first electrode plate includes a winding start end and a winding termination end. The first electrode plate includes a body section from a first weld portion to a second weld portion. The body section is equally divided into a plurality of subsections, each subsection being L in length. A total length of the weld portions of each subsection is not less than 5%×L, where 200 mm?L?1200 mm.

Abstract: The present disclosure provides a positioning method, including: obtaining a current local topology map established based on objects in an environment currently observed by a robot, obtaining a full topology map pre-established based on objects in a full environment in a preset area, the current local topology map and the full topology map including nodes representing the objects; matching a node pair to be associated constructed by two nodes in the current local topology map and two nodes in the full topology map; if a degree of association of the node pair to be associated is greater than a threshold, determining that the node pair to be associated is an associated node pair; and determining a pose of the robot according to one of a plurality of search ranches, with a largest number of associated node pairs.

Abstract: A method for controlling operations of an asynchronous FIFO memory includes: determining a current depth of the asynchronous FIFO memory according to at least one of a clock ratio, a burst length and a continuous transmission length, where the clock ratio is a ratio of a frequency of a first clock signal used by a master device to a frequency of a second clock signal used by a slave device; configuring one or more entries of the asynchronous FIFO memory to be used according to the current depth; and controlling a plurality of FIFO clock signals provided to the asynchronous FIFO memory according to the current depth. One FIFO clock signal corresponds to one entry, and one or more FIFO clock signals corresponding to one or more entries that are not configured according to the current depth are disabled.

Abstract: Provided are solid forms of a compound useful for treating cancer, pharmaceutical compositions thereof, and methods of treating cancer comprising administering the solid forms described herein to a patient in need thereof.

Abstract: Embodiments of this application provide a battery cell, a battery, and an electric apparatus. The battery cell may include an electrode assembly, a housing, an electrode terminal, and a current collector. The electrode assembly may include a first tab. The housing may be configured to accommodate the electrode assembly. The electrode terminal may be disposed in the housing, and the electrode terminal may include a first concave portion and a connecting portion at the bottom of the first concave portion. The current collector may be connected to the first tab and welded to the connecting portion.

Abstract: The present disclosure features citrate salts and pharmaceutical compositions useful for the treatment of BAF complex-related disorders. Also disclosed are methods for preparing compounds.

Abstract: A battery cell includes a housing, an electrode assembly, an end cover, and a current collecting member. The housing has an opening, the electrode assembly has a tab, the electrode assembly is configured to be accommodated in the housing, the end cover is configured to cover the opening, and the current collecting member is configured to connect the end cover to the tab to implement electrical connection between the end cover and the tab. The current collecting member is welded to the tab to form a first welded portion and a second welded portion, the current collecting member is welded to the end cover to form a third welded portion, the first welded portion is on an inner peripheral side of the third welded portion, and the second welded portion is on an outer peripheral side of the third welded portion.

Abstract: The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.

Abstract: A method for controlling operations of an asynchronous FIFO memory includes: determining a current depth of the asynchronous FIFO memory according to at least one of a clock ratio, a burst length and a continuous transmission length, where the clock ratio is a ratio of a frequency of a first clock signal used by a master device to a frequency of a second clock signal used by a slave device; configuring one or more entries of the asynchronous FIFO memory to be used according to the current depth; and controlling a plurality of FIFO clock signals provided to the asynchronous FIFO memory according to the current depth. One FIFO clock signal corresponds to one entry, and one or more FIFO clock signals corresponding to one or more entries that are not configured according to the current depth are disabled.

Abstract: A battery cell, a battery, an electric device, and a manufacturing device and method of battery cell are described. The battery cell includes a metal housing, an electrode assembly, and a conductive member, where the metal housing has an accommodating cavity; the electrode assembly is accommodated in the accommodating cavity, the electrode assembly includes a first tab, and the first tab is electrically connected to the metal housing; and the conductive member is disposed on an outer surface of the metal housing, and resistance of the conductive member is lower than that of the metal housing. In the charging and discharging process, current passes through the conductive member or passes through both the conductive member and the metal housing, in whichever cases, the resistance in the charging and discharging process of the battery cell is lower than that in the case of current passing through the metal housing only.

Abstract: The present disclosure features citrate salts and pharmaceutical compositions useful for the treatment of BAF complex-related disorders. Also disclosed are methods for preparing compounds.

Abstract: Provided are compounds and pharmaceutical compositions useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound or pharmaceutical composition described herein.

Abstract: Provided are solid forms of a compound useful for treating cancer, pharmaceutical compositions thereof, and methods of treating cancer comprising administering the solid forms described herein to a patient in need thereof.

Abstract: Provided herein is a tablet comprising 2-methyl-1-[(4-[-6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.